| Literature DB >> 33502319 |
H Sato1, Y Miyata1, H Inoue1, A Tanaka1, H Sagara1.
Abstract
Entities:
Keywords: Anti-IL-5 monoclonal antibody; Asthma; Chronic eosinophilic pneumonia; Extended interval dosing; Mepolizumab
Mesh:
Substances:
Year: 2021 PMID: 33502319 DOI: 10.18176/jiaci.0671
Source DB: PubMed Journal: J Investig Allergol Clin Immunol ISSN: 1018-9068 Impact factor: 4.333